Analgesic Effect of Non Invasive Stimulation : Comparison of rTMS and tDCS Efficacy
NCT ID: NCT01800136
Last Updated: 2019-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2013-01-13
2019-06-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Efficacy of rTMS and tDCS of the Motor Cortex in Patients With Chronic Neuropathic Pain
NCT02030626
Analgesic Stimulation Non-invasive of the Motor Cortex
NCT02854332
Study of RTMS Analgesic Effect in Chronic Neuropathic Pain,
NCT04936646
Analgesic Effects of rTMS in Peripheral Neuropathic Pain
NCT02010281
Efficacy of Non-Invasive Neuromodulation on Pain in Migraine
NCT07081685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
rTMS; tDCS
Repetitive Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation
Five sessions of HF-rTMS or tDCS applied daily during 5 consecutive days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Repetitive Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation
Five sessions of HF-rTMS or tDCS applied daily during 5 consecutive days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pharmacoresistant neuropathic pain during at least one year, without any change of the pharmacological treatment since at least one month
Exclusion Criteria
* ferromagnetic intracranial device
* implanted stimulator
* absence of contraceptive method for women of childbearing age
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Neurologie Fonctionnelle et Epileptologie, Hôpital Neurologique de Lyon et Unité " Intégration Centrale de la Douleur ", 1028 Inserm - UCBL
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-A01379-32
Identifier Type: OTHER
Identifier Source: secondary_id
2011.662
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.